SCHEMBL9350668

SCHEMBL9350668

O=c1cc(Cl)n(C2CCCCC2)c(=O)n1C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.44
CYP2C9 P11712 4/20 0.44
CYP2C19 P33261 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
PKM P14618 2/20 0.44
HTT P42858 4/20 0.41
TSHR P16473 3/20 0.41
POLB P06746 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP3A4 P08684 3/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 3/20 0.40
TP53 P04637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NR5A2 O00482 1/20 0.40
RAB9A P51151 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
MAPK1 P28482 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25827617 0.98 ALDH1A1 (0.41) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL11428167 0.84 GSK3A (0.44) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL11847806 0.75 GSK3A (0.54) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL9350770 0.74 ALDH1A1 (0.42) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL16004440 0.72 GSK3A (0.50) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL9351790 0.72 ALDH1A1 (0.38) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL4763682 0.72 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL11620873 0.71 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL11840108 0.71 JAK2 (0.47) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM
SCHEMBL3472019 0.71 ALDH1A1 (0.60) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0369744-B1 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-09-21 EP disclosed
US-5321029-A Vascular and skin disorders; bronchodilator BEECHAM-WUELFING GMBH & CO.K.G. (DE) 1994-06-14 US disclosed
EP-0369744-A2 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GmbH (DE) 1990-05-23 EP disclosed